CHG-2023-0182

Formulation Change for Verasenib. Analytical Method Change for Verasenib — routine update. Impacts 5 markets and 4 variations.

Change Number
CHG-2023-0182
Type
Formulation Change
Product
Verasenib
Status
Submitted
Owner
Aisha Okonkwo
Initiated
2023-09-16
Description

Analytical Method Change for Verasenib — routine update

Impacted Markets (5)
CN — ChinaSG — SingaporeAR — ArgentinaTR — TurkeySE — Sweden
Impacted Modules
3.2.P.33.2.S2.3.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved